8C99C7EA.png
  • GV-971
    • Product overview
    • China Phase III Clinical Trial
    • Mechanism of Action
    • Clinical Guideline
    • Q&A
  • Scientific Research Information
    • GREEN MEMORY
    • Post-marketing Study
    • IIR Program
    • Relevant Literature
  • Information and Services
    • Master e-Classes
    • Typical Case
    • Case Study
    • Assessment Scale
    • Conference Information
    • News Reports
    • Pharmacovigilance
  • Company Website
CN
8C99C7EA.png
CN
  • GV-971
    • Product overview
    • China Phase III Clinical Trial
    • Mechanism of Action
    • Clinical Guideline
    • Q&A
  • Scientific Research Information
    • GREEN MEMORY
    • Post-marketing Study
    • IIR Program
    • Relevant Literature
  • Information and Services
    • Master e-Classes
    • Typical Case
    • Case Study
    • Assessment Scale
    • Conference Information
    • News Reports
    • Pharmacovigilance
  • Company Website
021-50540520
pvg-banner.png banph3.jpg

Information and Services

INFORMATION

  • Master e-Classes
  • Typical Case
  • Case Study
  • Assessment Scale
  • Conference Information
  • News Reports
  • Pharmacovigilance
Case Study
Master e-Classes
Typical Case
Case Study
Assessment Scale
Conference Information
News Reports
Pharmacovigilance
Your location:
  • Home
  • Information and Services
  • Case Study
  • 0001.jpg
    2022/06/14

    Sodium Oligomannate in Treatment of Alzheimer’s Disease with Irritable Bowel Syndrome: A Case Report

  • 0002.jpg
    2022/06/14

    Sodium Oligomannate Combined with Levetiracetam in Treatment of Alzheimer’s Disease Associated with Epilepsy: A Case Report

  • 0003.jpg
    2022/06/14

    Sodium Oligomannate Ameliorates Cognitive Function, Behavioral and Psychological Symptoms and Living Function of an Alzheimer’s Disease Patient after Ovarian Cancer Surgery

  • 0004.jpg
    2022/06/14

    Sodium Oligomannate Combined with Donepezil in Treatment of Alzheimer Disease with ApoE ε3/ε4 Genotype: A Case Report

  • news1-981.png
    2022/06/14

    Sodium Oligomannate in Treatment of Vascular Dementia: A Case Report

  • 0006.jpg
    2022/06/14

    Sodium Oligomannate Combined with Memantine in Treatment of Behavioral Variant Frontotemporal Dementia: A Case Report

  • GV-971

    New hope for treating Alzheimer's disease worldwide

    img1.jpg
    webcode.png
  • Contact us

    Address: 421 Newton Road, Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, China

    Phone: 021-50540520

  • Quick Links
    • Home
    • Contact Us
    • Scientific Research Information
    • Pharmacovigilance
    • News Reports
    • Company Website

Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

The information on this website is provided as knowledge only and shall not replace medical advice and medical consultation provided by physicians or other qualified healthcare professionals. The information on this website shall not be used for disease diagnosis.

©2022 GreenValley Inc.beian.png 沪公网安备31011502018352号沪ICP备2021021810号-3  Powered by Yongsy

Copyright Notice Legal Notices Terms of use